Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome

被引：0

作者：

Shih-Chin Chen

Fei-Yuan Hsiao

Chii-Ming Lee

William Wei-Yuan Hsu

Churn-Shiouh Gau

机构：

[1] College of Medicine,Graduate Institute of Clinical Pharmacy

[2] National Taiwan University,Department of Pharmacy

[3] School of Pharmacy,Department of Internal Medicine

[4] College of Medicine,Department of Computer Science and Engineering

[5] National Taiwan University,undefined

[6] National Taiwan University Hospital,undefined

[7] College of Medicine,undefined

[8] National Taiwan University,undefined

[9] National Taiwan Ocean University,undefined

[10] Institute of Information Science,undefined

[11] Academia Sinica,undefined

[12] Center for Drug Evaluation,undefined

[13] Food and Drug Administration,undefined

[14] Ministry of Health and Welfare,undefined

来源：

BMC Cardiovascular Disorders | / 14卷

关键词：

Acute coronary syndrome (ACS); Percutaneous coronary intervention (PCI); Clopidogrel; Dual antiplatelet therapy; Drug eluting stent (DES);

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 225 条

[1]

Budaj A(2002)Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups Circulation 106 1622-1626

[2]

Yusuf S(2006)Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents J Am Coll Cardiol 48 2584-2591

[3]

Mehta SR(2001)Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 527-533

[4]

Fox KA(2001)Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 494-502

[5]

Tognoni G(2007)Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment Circulation 116 745-754

[6]

Zhao F(2011)2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons J Am Coll Cardiol 57 e215-e367

[7]

Chrolavicius S(2012)2012 ESC Guidelines on acute myocardial infarction (STEMI) Eur Heart J 33 2501-2502

[8]

Hunt D(2011)ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J 32 2999-3054

[9]

Keltai M(2007)Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern Circulation 115 1440-1455

[10]

Franzosi MG(2007)Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden N Engl J Med 356 1009-1019

← 1 2 3 4 5 6 7 8 9 10 →